Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experience with NORPLANT in Egypt

M M Shaaban1

  • 1Department of Obstetrics and Gynecology, School of Medicine, Assiut University, Egypt.

Annals of Medicine
|April 1, 1993
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of replacement of antibiotics with thyme and celery seed mixture on the feed intake and digestion, ruminal fermentation, blood chemistry, and milk lactation of lactating Barki ewes.

Food & function·2020
Same author

Rising cesarean section rates, a patient's perspective: experience from a high birth rate country.

Clinical and experimental obstetrics & gynecology·2014
Same author

Blood metabolites and hormone-based programmed breeding treatments in anovular lactating dairy cows.

Journal of dairy science·2011
Same author

The use of nomegestrol acetate subdermal contraceptive implant, uniplant, during lactation.

Contraception·1996
Same author

The perimenopause and contraception.

Maturitas·1996
Same author

Multicenter clinical trial on the efficacy and acceptability of a single contraceptive implant of nomegestrol acetate, Uniplant.

Contraception·1996

Norplant, a long-term contraceptive implant, has demonstrated a 5-year continuation rate of 51% and a low pregnancy rate in Egypt. It is safe for women and does not negatively impact breastfeeding infants.

Area of Science:

  • Reproductive Health
  • Contraception
  • Public Health

Background:

  • Norplant, a progestogen-releasing contraceptive implant, has been available in Egypt since the early 1980s.
  • Over 3000 women have utilized Norplant at Assiut University Family Clinic, highlighting its adoption in the region.
  • Egypt presents a unique need for long-term contraceptive methods due to cultural factors limiting sterilization acceptance.

Purpose of the Study:

  • To evaluate the safety and efficacy of Norplant as a long-term contraceptive method in the Egyptian population.
  • To assess the impact of Norplant on women's health indicators, including lipid profile, liver function, and blood coagulation.
  • To investigate the effects of early Norplant initiation post-delivery on lactational performance and infant development.

Main Methods:

Keywords:
AfricaArab CountriesAttitudeBehaviorBreast FeedingClinical ResearchClinical TrialsContraceptionContraception ContinuationContraception FailureContraceptive AgentsContraceptive Agents, FemaleContraceptive Agents, ProgestinContraceptive ImplantsContraceptive MethodsContraceptive UsageDeveloping CountriesEgyptFamily PlanningFocus GroupsHealthInfant NutritionLevonorgestrelLiterature ReviewMediterranean CountriesNorthern AfricaNutritionPsychological FactorsPublic HealthResearch ReportSafety

Related Experiment Videos

  • Analysis of clinical data from over 3000 women using Norplant at Assiut University Family Clinic.
  • Clinical pharmacology studies to assess safety parameters (lipid profile, liver function, coagulation).
  • Studies examining the effects of postpartum Norplant initiation on breastfeeding and infant development.
  • Focus-group discussions to understand user attitudes and identify areas for service improvement.

Main Results:

  • A 5-year cumulative continuation rate of 51% and a pregnancy rate of 1.8 per 100 women were observed.
  • Clinical pharmacology studies revealed no adverse effects on lipid profiles, liver functions, or blood coagulation.
  • Initiating Norplant shortly after delivery showed no negative impact on breastfeeding or infant physical/psychomotor development.
  • User feedback indicated a need for enhanced educational materials addressing cultural considerations.

Conclusions:

  • Norplant is a safe and acceptable long-term contraceptive option in Egypt, meeting a significant need for reversible, long-acting methods.
  • The contraceptive's safety profile is confirmed, with no detrimental effects on key physiological markers or infant development.
  • Improving patient education, incorporating cultural sensitivities, can further enhance Norplant's acceptance and continuation rates.